Table: Kyorin Pharmaceutical - 9-MTH group results

Kyorin Pharmaceutical

05/02/2025 06:31

Feb 5 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             89.29               87.27           123.40    
                 (+2.3 pct)          (+8.1 pct)       (+3.2 pct)  
  Operating          3.12                4.80             6.50    
                 (-35.1 pct)                          (+4.3 pct)  
  Recurring          3.75                5.39             6.90    
                 (-30.4 pct)                          (+1.1 pct)  
  Net                2.44                4.15             5.00    
                 (-41.2 pct)                          (-8.7 pct)  
  EPS             42.46 yen           72.32 yen        87.03 yen  
  Ann Div                             52.00 yen        52.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             32.00 yen        32.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T